These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33049271)

  • 21. Cutaneous CD30 positive large T cell lymphoma of the upper lip: a rare presentation.
    Chandu A; Mitchell DA; Corrigan AM
    Br J Oral Maxillofac Surg; 1997 Jun; 35(3):193-5. PubMed ID: 9212298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary "cutaneous" T-cell anaplastic large cell lymphoma, CD30+, neutrophil-rich variant with subcutaneous panniculitic lesions, in a post-renal transplant patient: report of unusual case and literature review.
    Salama S
    Am J Dermatopathol; 2005 Jun; 27(3):217-23. PubMed ID: 15900125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD56 expression in a case of primary cutaneous CD30+ anaplastic large cell lymphoma.
    Chang SE; Park IJ; Huh J; Choi JH; Sung KJ; Moon KC; Koh JK
    Br J Dermatol; 2000 Apr; 142(4):766-70. PubMed ID: 10792229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The spectrum of CD30+ T cell lymphoproliferative disorders in the skin.
    Kartan S; Johnson WT; Sokol K; Alpdogan O; Gru AA; Nikbakht N; Porcu P
    Chin Clin Oncol; 2019 Feb; 8(1):3. PubMed ID: 30691273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD30 As a Target for the Treatment of Cutaneous T-Cell Lymphoma.
    Prince HM
    J Clin Oncol; 2015 Nov; 33(32):3691-6. PubMed ID: 26392103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Classification of primary cutaneous T-cell lymphomas.
    Willemze R; Beljaards RC; Meijer CJ
    Histopathology; 1994 May; 24(5):405-15. PubMed ID: 8088712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD30 (Ki-1)-positive primary cutaneous T-cell lymphoma: report of spontaneous resolution.
    Artemi P; Wong DA; Mann S; Regan W
    Australas J Dermatol; 1997 Nov; 38(4):206-8. PubMed ID: 9431717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nodal Involvement by CD30
    Lezama LS; Gratzinger D
    Arch Pathol Lab Med; 2018 Jan; 142(1):139-142. PubMed ID: 29257929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary CD30-positive cutaneous T-cell lymphomas and lymphomatoid papulosis frequently express cytotoxic proteins.
    Boulland ML; Wechsler J; Bagot M; Pulford K; Kanavaros P; Gaulard P
    Histopathology; 2000 Feb; 36(2):136-44. PubMed ID: 10672058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SATB1 overexpression promotes malignant T-cell proliferation in cutaneous CD30+ lymphoproliferative disease by repressing p21.
    Wang Y; Gu X; Zhang G; Wang L; Wang T; Zhao Y; Zhang X; Zhou Y; Kadin M; Tu P
    Blood; 2014 May; 123(22):3452-61. PubMed ID: 24747435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of Fas and Fas-ligand in primary cutaneous T-cell lymphoma (CTCL): association between lack of Fas expression and aggressive types of CTCL.
    Zoi-Toli O; Vermeer MH; De Vries E; Van Beek P; Meijer CJ; Willemze R
    Br J Dermatol; 2000 Aug; 143(2):313-9. PubMed ID: 10951138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [CD8-positive, CD30-negative cutaneous T-cell lymphoma simulating pyoderma gangrenosum].
    Dueck D; Hermes B; Audring H; Kohl PK
    Hautarzt; 2002 Feb; 53(2):114-7. PubMed ID: 11963190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD30 expression and proliferative fraction in nontransformed mycosis fungoides.
    Edinger JT; Clark BZ; Pucevich BE; Geskin LJ; Swerdlow SH
    Am J Surg Pathol; 2009 Dec; 33(12):1860-8. PubMed ID: 19898220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cutaneous lymphoma at the Dermatology Day conference, Paris 2010].
    Battistella M
    Ann Dermatol Venereol; 2011 May; 138(5 Suppl 2):H1-11. PubMed ID: 21703464
    [No Abstract]   [Full Text] [Related]  

  • 35. Recurrence of primary cutaneous CD30-positive lymphoproliferative disorder following COVID-19 vaccination.
    Brumfiel CM; Patel MH; DiCaudo DJ; Rosenthal AC; Pittelkow MR; Mangold AR
    Leuk Lymphoma; 2021 Oct; 62(10):2554-2555. PubMed ID: 33974494
    [No Abstract]   [Full Text] [Related]  

  • 36. Primary cutaneous Ki-1(CD30) positive anaplastic large cell lymphoma in childhood.
    Tomaszewski MM; Moad JC; Lupton GP
    J Am Acad Dermatol; 1999 May; 40(5 Pt 2):857-61. PubMed ID: 10321635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathologic and microenvironmental analysis of primary cutaneous CD30-positive lymphoproliferative disorders: a 26 year experience from an academic medical center in Brazil.
    Ferreira CR; Zhao S; Sanches JA; Miyashiro D; Cury-Martins J; Azevedo RS; Zerbini MCN; Natkunam Y; Gratzinger D
    Diagn Pathol; 2019 Oct; 14(1):115. PubMed ID: 31640798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunophenotypic analysis of benign and malignant cutaneous lymphoid infiltrates.
    Rest EB; Horn TD
    Clin Dermatol; 1991; 9(2):261-72. PubMed ID: 1660786
    [No Abstract]   [Full Text] [Related]  

  • 39. No TP63 rearrangements in a selected group of primary cutaneous CD30+ lymphoproliferative disorders with aggressive clinical course.
    Schrader AM; Chung YY; Jansen PM; Szuhai K; Bastidas Torres AN; Tensen CP; Willemze R
    Blood; 2016 Jul; 128(1):141-3. PubMed ID: 27146432
    [No Abstract]   [Full Text] [Related]  

  • 40. Primary cutaneous CD30-positive T cell lymphoproliferative disorders associated with polymethylmethacrylate: An unfortunate coincidence or a causal relationship?
    de Castro E Souza B; Miyashiro D; Sotto MN; Sanches JA
    Dermatol Ther; 2021 Mar; 34(2):e14824. PubMed ID: 33527574
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.